Immunetics Inc., a Boston company focused on technologies for diagnosing and screening for infectious diseases, said Monday that its board of directors has appointed John Yonkin as chief executive.

Yonkin succeeds Dr. Andrew Levin, the company’s founder. Levin will remain president at Immunetics and will continue to lead its research and development group.